This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Pacelli, F. Articles by Doglietto, G. B. Search for Related Content PubMed PubMed Citation Articles by Pacelli, F. Articles by Doglietto, G. B. Pubmed/NCBI databases Compound via MeSH Substance via MeSH Medline Plus Health Information Stomach Cancer Social Bookmarking                         What's this?

Parenteral Nutrition Does Not Stimulate Tumor Proliferation in Malnourished Gastric Cancer Patients

Fabio Pacelli, MD^*, Maurizio Bossola, MD^*, Laura Teodori, MD, Maria Luisa Trinca, MD, Antonio Tortorelli, MD^*, Fausto Rosa, MD^* and Giovan Battista Doglietto, MD^*

From the ^* Istituto di Clinica Chirurgica, Università Cattolica del Sacro Cuore, Roma, Italy; and the Divisione di Fisica e Scienze Biomediche, ENEA, CRE, Casaccia, Roma, Italy

Correspondence: Maurizio Bossola, MD, Istituto di Clinica Chirurgica, Università Cattolica del Sacro Cuore, Largo A. Gemelli, 8-00168 Roma, Italy. Electronic mail may be sent to maubosso{at}tin.it.

Background: The present study evaluated the effects of preoperative parenteral nutrition (PN) on tumor cell proliferation in malnourished gastric cancer patients. Methods: Twenty malnourished patients affected by gastric cancer were randomized to receive the standard hospital oral diet (control group) or the standard hospital oral diet plus PN (PN group; 0.2 g/kg/d of nitrogen and 30 nonprotein kcal/kg/d). Samples of tumor tissue and surrounding health mucosa were taken by endoscopic biopsies and from the operative specimen, immediately after resection. Tissues were sent for histologic examination and prepared for flow cytometry and for the measurement of the uptake of bromodeoxyuridine (BduR) by cells after in vitro exposure to the agent. The BduR uptake is largely used to assess the proportion of cells actively synthesizing DNA and is one of the principle methods used to measure tumor proliferation. Results: In the PN group, the mean percentage of tumor cells incorporating BduR was 2.51% ± 1.7% in the endoscopic samples and 1.52% ± 0.8% in the operative specimens (p = .2). In the normal mucosa, the mean percentage of cells incorporating BduR was 2.24% ± 1.8% and 1.13% ± 1.1%, respectively (p = .1). In the control group, the percentage of cells incorporating BduR in the normal mucosa was 1.26% ± 1.1% at endoscopy and 0.41% ± 0.3% at surgery (p = .2), whereas the percentage of cells incorporating BduR in the tumor tissue was 1.41% ± 1.2% at endoscopy and 0.48% ± 0.6% at surgery (p = .2). The percentage of S-phase cells documented by flow cytometry in the PN group was: in the tumor, 6.6% ± 2.9% in the endoscopic samples and 5.7% ± 2.5% in the operative specimens (p = .6); in the normal mucosa, 5.8% ± 2.5% at endoscopy and 5.4% ± 0.9% at surgery (p = .7). In the control group, the percentage of proliferating cells measured by flow cytometry was 4.9% ± 3.2% in the normal mucosa taken by endoscopic biopsy and 5.3% ± 1.4% in the normal mucosa taken from the operative specimens (p = .8), whereas it was 11.4% ± 7.2% in the tumor taken with endoscopic biopsy and 9.7% ± 4% in the tumor tissue taken from the surgical specimens (p = .7). Conclusions: The present study suggests that PN does not stimulate tumor proliferation in malnourished patients affected by gastric cancer.

Journal of Parenteral and Enteral Nutrition, Vol. 31, No. 6, 451-455 (2007)
DOI: 10.1177/0148607107031006451


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				D. A. August, M. B. Huhmann, and the American Society for Parenteral and Enteral Nu A.S.P.E.N. Clinical Guidelines: Nutrition Support Therapy During Adult Anticancer Treatment and in Hematopoietic Cell Transplantation JPEN J Parenter Enteral Nutr, September 1, 2009; 33(5): 472 - 500. [Full Text] [PDF]